Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: QUIDEL CORP
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-07-30 to 2024-04-27
Current total value of award: $92667601.5
Description: RADX ATP ACCELERATED MANUFACTURING SCALE-UP OF RAPID POINT-OF-CARE ANTIGEN TESTS FOR COVID-19 DIAGNOSIS